Viatris Inc. (NASDAQ: VTRS) stands as a global healthcare powerhouse, uniquely merging the worlds of generics and brands to address global healthcare needs comprehensively. Their mission, to enhance worldwide health at every life stage, is evidenced by providing access to high-quality medicines for approximately 1 billion patients in 2022 alone. With an extensive portfolio, a robust global supply chain, and scientific expertise, Viatris reaches people worldwide, from birth to end-of-life, offering solutions for a wide range of health challenges. Based in the U.S., they operate globally from centers in Pittsburgh, Shanghai, and Hyderabad, India.